Interaction between DNA-cationic liposome complexes and erythrocytes is animportant factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid
F. Sakurai et al., Interaction between DNA-cationic liposome complexes and erythrocytes is animportant factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid, GENE THER, 8(9), 2001, pp. 677-686
Recent studies have indicated that there are many barriers to successful sy
stemic gene delivery via cationic lipid vectors using the intravenous route
. The purpose of this study was to investigate the effect of binding and in
teraction between erythrocytes, a major constituent of blood cells, and the
complexes, in relation to the role of the helper lipid, on the in vivo gen
e delivery to the lung following intravenous injection. We used three types
of cationic lipid vectors, DNA-DOTMA/Chol liposome complexes, DNA-DOTMA li
posome complexes, and DNA-DOTMA/DOPE liposome complexes. Although the three
types of vectors bind to murine blood cells in vivo and in vitro. DOTMA/Ch
ol and DOTMA complexes with a higher in vivo transfection activity do not i
nduce fusion between erythrocytes, whereas DOTMA/DOPE complexes, a less eff
icient vector in vivo, induce fusion between the erythrocytes after a short
incubation period. Pre-incubation of DOTMA/DOPE complexes with erythrocyte
s significantly reduced the transfection efficiency while DOTMA/Chol- and D
OTMA complexes were more resistant to such treatment. The differences in th
e physicochemical and structural properties of these complexes could explai
n the differences in interaction with erythrocytes and subsequent gene expr
ession. Lipids in DOTMA/Chol and DOTMA complexes have a stable lamellar str
ucture. However, lipids in DOTMA/DOPE complexes have a highly curved struct
ure with high fluidity. These results indicate that the interaction with er
ythrocytes depends on the properties of the cationic lipid vectors and this
is an important factor for intravenous gene delivery using cationic lipid
vectors.